Get the Stockscreener App
22.11
0.73%
0.16
After Hours:
22.12
0.01
+0.05%
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $22.11, with a volume of 4.32M.
It is up +0.73% in the last 24 hours and down -7.84% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$21.95
Open:
$22.04
24h Volume:
4.32M
Relative Volume:
0.59
Market Cap:
$11.36B
Revenue:
$11.89B
Net Income/Loss:
$-560.00M
P/E Ratio:
-20.10
EPS:
-1.1
Net Cash Flow:
$191.00M
1W Performance:
-4.49%
1M Performance:
-7.84%
6M Performance:
-20.58%
1Y Performance:
-39.49%
1-Day Range:
$21.95
$22.39
1-Week Range:
$21.63
$23.28
52-Week Range:
$21.33
$37.74
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.11 | 11.27B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Leading vs lagging indicators on Baxter International Inc. performancePortfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com
Will Baxter International Inc. benefit from macro trendsTrade Risk Summary & Short-Term High Return Ideas - newser.com
Published on: 2025-10-13 09:32:46 - newser.com
Published on: 2025-10-13 04:36:01 - newser.com
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Sivik Global Healthcare LLC Sells 100,000 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Why Baxter (BAX) Stock Is Falling Today - Yahoo Finance
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Baxter International Inc Options Spot-On: On July 31st, 222.65K Contracts Were Traded, With 75,527 Open Interest - 富途牛牛
What Fibonacci levels say about Baxter International Inc. reboundJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Saudi Arabia Dialysis Market Report 2025-2033, Competitive Analysis of Asahi Kasei, B. Braun Melsungen, Baxter Int'l, Becton Dickinson and Co, DaVita, Fresenius Medical Care, JMS, MedtronicResearchAndMarkets.com - The AI Journal
Baxter International (NYSE:BAX) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Should you hold or exit Baxter International Inc. nowJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com
Will Baxter International Inc. bounce back from current supportMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Baxter Bros Inc. Grows Stock Position in Honeywell International Inc. $HON - MarketBeat
Dialysis Market See Incredible Growth 2025-2032 |Fresenius Medical Care, Baxter International, B Braun Melsungen AG Avitum, Nipro Corporation - industrytoday.co.uk
Can Baxter International Inc. (BTL) stock sustain free cash flowNew Guidance & AI Powered Market Trend Analysis - newser.com
Will Baxter International Inc. stock benefit from Fed rate cutsTrade Risk Report & Detailed Earnings Play Alerts - newser.com
How Baxter International Inc. stock performs during market turbulenceJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Baxter International (BAX) Receives a Buy from Evercore ISI - The Globe and Mail
Baxter International Sees Unusually Large Options Volume (NYSE:BAX) - MarketBeat
Evercore ISI Lowers Baxter International (NYSE:BAX) Price Target to $31.00 - MarketBeat
Evercore ISI Adjusts Baxter International Price Target to $31 From $33, Maintains Outperform Rating - MarketScreener
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $31 - 富途牛牛
Is Baxter International Inc a good long term investmentHealthcare Stock Analysis & Learn the Secrets of Pro Traders - earlytimes.in
Risk vs reward if holding onto Baxter International Inc.Market Movers & High Accuracy Buy Signal Tips - newser.com
How the Narrative for Baxter International Is Evolving Amid Leadership Changes and Mixed Analyst Views - Yahoo
Detecting price anomalies in Baxter International Inc. with AI2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com
Is Baxter International Inc. stock attractive for growth fundsWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
1 Healthcare Stock with Exciting Potential and 2 Facing Challenges - The Globe and Mail
Measuring Baxter International Inc.’s beta against major indices2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
First bridge replacement finished after Helene, servicing Baxter Healthcare - WCNC
Will Baxter International Inc. stock beat Nasdaq index returns2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Is Baxter International Inc. stock a buy on weaknessQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How Baxter International Inc. (BTL) stock performs in volatility spikesEarnings Trend Report & AI Enhanced Trading Alerts - newser.com
Healthcare Industry Resilience Collaborative (HIRC) Awards Gold Level Resiliency Badge to Baxter International Inc. (BAX) - MSN
What analysts say about Baxter International Inc stockGeopolitical Risk Analysis & Breakout Portfolio Performance - earlytimes.in
What drives PYXS stock priceRisk-Reward Ratio Analysis & Small Budget Trading Ideas - earlytimes.in
Baxter names new Senior VP and Chief Accounting Officer - MSN
Is Baxter International Inc BTL a good long term investmentEquity Performance Review & Rapid Capital Gain - earlytimes.in
Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha
Advanced analytics toolkit walkthrough for Baxter International Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):